IBDEI2C8 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,39641,0)
 ;;=S02.3XXA^^153^1927^22
 ;;^UTILITY(U,$J,358.3,39641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39641,1,3,0)
 ;;=3^Fx of Orbital Floor,Init Encntr for Closed Fx
 ;;^UTILITY(U,$J,358.3,39641,1,4,0)
 ;;=4^S02.3XXA
 ;;^UTILITY(U,$J,358.3,39641,2)
 ;;=^5020312
 ;;^UTILITY(U,$J,358.3,39642,0)
 ;;=H51.9^^153^1927^7
 ;;^UTILITY(U,$J,358.3,39642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39642,1,3,0)
 ;;=3^Binocular Movement Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,39642,1,4,0)
 ;;=4^H51.9
 ;;^UTILITY(U,$J,358.3,39642,2)
 ;;=^5006258
 ;;^UTILITY(U,$J,358.3,39643,0)
 ;;=H49.13^^153^1927^19
 ;;^UTILITY(U,$J,358.3,39643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39643,1,3,0)
 ;;=3^Fourth Trochlear Nerve Palsy,Bilateral
 ;;^UTILITY(U,$J,358.3,39643,1,4,0)
 ;;=4^H49.13
 ;;^UTILITY(U,$J,358.3,39643,2)
 ;;=^5006186
 ;;^UTILITY(U,$J,358.3,39644,0)
 ;;=H47.013^^153^1927^26
 ;;^UTILITY(U,$J,358.3,39644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39644,1,3,0)
 ;;=3^Ischemic Optic Neuropathy,Bilateral
 ;;^UTILITY(U,$J,358.3,39644,1,4,0)
 ;;=4^H47.013
 ;;^UTILITY(U,$J,358.3,39644,2)
 ;;=^5006107
 ;;^UTILITY(U,$J,358.3,39645,0)
 ;;=D86.82^^153^1927^33
 ;;^UTILITY(U,$J,358.3,39645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39645,1,3,0)
 ;;=3^Multiple Cranial Nerve Palsies in Sarcoidosis
 ;;^UTILITY(U,$J,358.3,39645,1,4,0)
 ;;=4^D86.82
 ;;^UTILITY(U,$J,358.3,39645,2)
 ;;=^5002447
 ;;^UTILITY(U,$J,358.3,39646,0)
 ;;=H49.883^^153^1927^38
 ;;^UTILITY(U,$J,358.3,39646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39646,1,3,0)
 ;;=3^Paralytic Strabismus,Bilateral
 ;;^UTILITY(U,$J,358.3,39646,1,4,0)
 ;;=4^H49.883
 ;;^UTILITY(U,$J,358.3,39646,2)
 ;;=^5006205
 ;;^UTILITY(U,$J,358.3,39647,0)
 ;;=H49.23^^153^1927^44
 ;;^UTILITY(U,$J,358.3,39647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39647,1,3,0)
 ;;=3^Sixth Abducent Nerve Palsy,Bilateral
 ;;^UTILITY(U,$J,358.3,39647,1,4,0)
 ;;=4^H49.23
 ;;^UTILITY(U,$J,358.3,39647,2)
 ;;=^5006190
 ;;^UTILITY(U,$J,358.3,39648,0)
 ;;=H49.03^^153^1927^48
 ;;^UTILITY(U,$J,358.3,39648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39648,1,3,0)
 ;;=3^Third Oculomotor Nerve Palsy,Bilateral
 ;;^UTILITY(U,$J,358.3,39648,1,4,0)
 ;;=4^H49.03
 ;;^UTILITY(U,$J,358.3,39648,2)
 ;;=^5006182
 ;;^UTILITY(U,$J,358.3,39649,0)
 ;;=H34.03^^153^1927^51
 ;;^UTILITY(U,$J,358.3,39649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39649,1,3,0)
 ;;=3^Transient Retinal Artery Occlusion,Bilateral
 ;;^UTILITY(U,$J,358.3,39649,1,4,0)
 ;;=4^H34.03
 ;;^UTILITY(U,$J,358.3,39649,2)
 ;;=^5005555
 ;;^UTILITY(U,$J,358.3,39650,0)
 ;;=Z90.01^^153^1928^1
 ;;^UTILITY(U,$J,358.3,39650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39650,1,3,0)
 ;;=3^Acquired Absence of Eye
 ;;^UTILITY(U,$J,358.3,39650,1,4,0)
 ;;=4^Z90.01
 ;;^UTILITY(U,$J,358.3,39650,2)
 ;;=^322068
 ;;^UTILITY(U,$J,358.3,39651,0)
 ;;=H04.552^^153^1928^2
 ;;^UTILITY(U,$J,358.3,39651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39651,1,3,0)
 ;;=3^Acquired Stenosis of Left Nasolacrimal Duct
 ;;^UTILITY(U,$J,358.3,39651,1,4,0)
 ;;=4^H04.552
 ;;^UTILITY(U,$J,358.3,39651,2)
 ;;=^5004539
 ;;^UTILITY(U,$J,358.3,39652,0)
 ;;=H04.551^^153^1928^3
 ;;^UTILITY(U,$J,358.3,39652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39652,1,3,0)
 ;;=3^Acquired Stenosis of Right Nasolacrimal Duct
 ;;^UTILITY(U,$J,358.3,39652,1,4,0)
 ;;=4^H04.551
 ;;^UTILITY(U,$J,358.3,39652,2)
 ;;=^5004538
 ;;^UTILITY(U,$J,358.3,39653,0)
 ;;=H01.115^^153^1928^4
 ;;^UTILITY(U,$J,358.3,39653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39653,1,3,0)
 ;;=3^Allergic Dermatitis of Left Lower Eyelid
